News
After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...
Phase 1b studies for ABI-1179 and ABI-5366 running concurrently ... Assembly Bio’s ability to maintain financial resources necessary to continue its research activities, clinical studies and other ...
The initial implementation phase of myUABResearch, the university’s new electronic research administration system, is on ...
Recognized for its biotech-first focus, innovation in clinical trial delivery, and best-in-class client experience, Novotech sets the global standard in contract research for biotechs and small- ...
In recognition of its innovation, client-focused delivery, and global impact, Novotech has been awarded the 2025 Global Biotechnology Contract Research Organization (CRO) Company of the Year by Frost ...
Thermo Fisher Scientific’s Accelerator™ Drug Development solutions, which integrate services for contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs) ...
The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.
The next frontier in clinical development is modelling feasibility and continuous scenario-planning, even amid changing ...
Read highlights things to do, places to go and people to know in the Greater Lowell area. Have news to share? Send it to news ...
While biopharmaceutical technologies have made substantial strides in treating diseases, drug research and development ...
Bids for Blackstone’s clinical trials business CMAX are believed to be due in coming days and so far Australian private ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results